Comparison of quality and hemorragic risk of oral anticoagulant therapy using acenocoumarol versus warfarin;Comparación de la calidad y el riesgo hemorrágico del tratamiento anticoagulante oral con acenocumarol frente a warfarina

Medicina Clinica

Volumn 131, Issue 3, 2008, Pages 96-97

  Oliva Berini, Elvira ^a   Álvarez, Pilar Galán ^a   Onrubia, Ana María Pacheco ^a  

^a Hospital Mateu Orfila   (Spain)

Author keywords

Acenocoumarol; Hemorragic risk; Warfarin

Indexed keywords

ACENOCOUMAROL; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG STABILITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; TREATMENT DURATION;

EID: 46449094912     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13124012     Document Type: Article

References (7)

1. Pattacini C, Manotti C, Pini M, Quintavalla R, Dettori AG. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol). Thromb Haemost. 1994;71:188-91.
2. Gadisseur AP, Van der Meer FJ, Adriaansen HJ, Fihn SD, Rosendaal FR. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br J Haematol. 2002;117:940-6.
3. Fihn SD, Gadisseur AAP, Pasterkamp E, Van der Meer FJ, Mimi Breukink-Engbers WG, Geven-Boere LM, et al. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon. Thromb Haemost. 2003;90:260-6.
4. Palareti G, Legnani C, Guazzaloca G, Leila V, Cosmi B, Lunghi B, et al. Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol. 2005;129:72-8.
5. Barcellona D, Vannini ML, Fenu L, Balestrieri C, Marongiu F. Warfarin or Acenocoumarol: which is better in the management of oral anticoagulants? Thromb Haemost. 1998;80:899-902.
6. Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160:1612-7.
7. Penning-Van Beest FJA, Van Meegen E, Rosendaal FR, Stricker BHC. Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation. Thromb Haemost. 2001;86:569-74.